An in vitro assessment for evaluating the efficiency of β‐ d ‐mannuronic acid (M2000) in myelodysplastic syndrome-Reference-Cited by-同舟云学术

An in vitro assessment for evaluating the efficiency of β‐ d ‐mannuronic acid (M2000) in myelodysplastic syndrome

Published:2018-12-10 Issue:8 Volume:234 Page:12971-12977
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Bakhtiari Tahereh¹,Ghaderi Afshin²,Safaee Nodehi Sayyed Reza²,Aghazadeh Zahra¹,Tofighi Zavareh Farzaneh¹³,Jafarnezhad‐Ansariha Fahimeh¹,Barati Anis⁴,Mirshafiey Abbas¹³^ORCID

Affiliation:

1. Department of Immunology School of Public Health, Tehran University of Medical Sciences Tehran Iran

2. Department of Internal Medicine Hematology and Medical Oncology Ward, Cancer Research Centre. Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Science Tehran Iran

3. Research Centre for Immunodeficiencies, Children's Medical Centre, Tehran University of Medical Sciences Tehran Iran

4. Department of Biology College of Sciences, Shiraz University Shiraz Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27966

Reference48 articles.

1. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis

2. Hematological improvement of patients with active rheumatoid arthritis by β‐d‐mannuronic acid (M2000) as a novel NSAID with immunosuppressive property;Ahmadi H.;Iranian Journal of Allergy, Asthma and Immunology,2017

3. Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis

4. A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-d-mannuronic acid in rheumatoid arthritis patients

5. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of HIF‑1α expression with apoptosis and cell cycle in bone marrow mesenchymal stem cells from patients with myelodysplastic syndrome;Molecular Medicine Reports;2022-05-30

2. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients;Iranian Journal of Allergy, Asthma and Immunology;2022-02-08

3. Emerging roles of circular RNAs in systemic lupus erythematosus;Molecular Therapy - Nucleic Acids;2021-06

4. Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cell;Immunopharmacology and Immunotoxicology;2021-05-31

5. Mannuronic Acid in Low‐Risk and Intermediate‐1‐Risk Myelodysplastic Syndromes;The Journal of Clinical Pharmacology;2020-02-16